Note*: This report requires 5-10 business days to complete.
DelveInsight’s “Idiopathic pulmonary fibrosis (IPF) - Market Insights, Epidemiology and Market Size Forecast-2020” Reports provides an overview of the disease and global market size of the Idiopathic pulmonary fibrosis (IPF) for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Idiopathic pulmonary fibrosis (IPF) from 2010-2020.Hemophilia is a bleeding disorder that slows the blood clotting process. People with this condition experience prolonged bleeding or oozing following an injury, surgery, or having a tooth pulled. The major types of this condition are hemophilia A (also known as classic hemophilia or factor VIII deficiency) and hemophilia B (also known as Christmas disease or factor IX deficiency). Although the two types have very similar signs and symptoms, they are caused by mutations in different genes. Gene therapy might eventually help people with hemophilia begin producing their own clotting factor, alleviating the need for or reducing the number of weekly infusions.
Scope
• Report covers the disease overview including etiology, pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2010-2020.
• It also provides Market size of Idiopathic pulmonary fibrosis (IPF) for United States, EU5 and Japan from 2010 and forecasted Market size to 2020
'
Table of Contents
• Idiopathic pulmonary fibrosis (IPF)
• Disease overview:
• Pathophysiology:
• Symptoms of disease:
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• United States
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Idiopathic pulmonary fibrosis (IPF) Market
• Global Epidemiology of Idiopathic pulmonary fibrosis (IPF) Forecasted to 2020
• Global Market size (2011-2014)
• Global Forecasted Market size (2015-2020)
• Global Market Size by Geography
• Market size of US (2011-2014)
• Forecasted Market size of US (2015-2020)
• Market size of Europe
• Market size of Germany (2011-2014)
• Forecasted Market size of Germany (2015-2020)
• Market size of United Kingdom (2011-2014)
• Forecasted Market size of United Kingdom (2015-2020)
• Market size of France (2011-2014)
• Forecasted Market size of France (2015-2020)
• Market size of Italy (2011-2014)
• Forecasted Market size of Italy (2015-2020)
• Market size of Spain (2011-2014)
• Forecasted Market size of Spain (2015-2020)
• Market size of Japan (2011-2014)
• Forecasted Market Size of Japan (2015-2020)
• Market size of ROW (2011-2014)
• Forecasted Market size of ROW (2015-2020)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Idiopathic pulmonary fibrosis (IPF) Drug Sales (USD Millions), (2014-2020)
• Table 6: Global Epidemiology of Idiopathic pulmonary fibrosis (IPF) (2011-2020)
• Table 7: Idiopathic pulmonary fibrosis (IPF) Global Market Size (USD Millions), (2011-2014)
• Table 8: Idiopathic pulmonary fibrosis (IPF) Global Market Size (USD Millions), (2015-2020)
• Table 9: Idiopathic pulmonary fibrosis (IPF) US Market Size (USD Millions), (2011-2014)
• Table 10: Idiopathic pulmonary fibrosis (IPF) US Market Size (USD Millions), (2015-2020)
• Table 11: Idiopathic pulmonary fibrosis (IPF) United Kingdom Market Size (USD Millions), (2011-2014)
• Table 12: Idiopathic pulmonary fibrosis (IPF) Germany Market Size (USD Millions), (2015-2020)
• Table 13: Idiopathic pulmonary fibrosis (IPF) United Kingdom Market Size (USD Millions), (2011-2014)
• Table 14: Idiopathic pulmonary fibrosis (IPF) United Kingdom Market Size (USD Millions), (2015-2020)
• Table 15: Idiopathic pulmonary fibrosis (IPF) France Market Size (USD Millions), (2011-2014)
• Table 16: Idiopathic pulmonary fibrosis (IPF) France Market Size (USD Millions), (2015-2020)
• Table 17: Idiopathic pulmonary fibrosis (IPF) Italy Market Size (USD Millions), (2011-2014)
• Table 18: Idiopathic pulmonary fibrosis (IPF) Italy Market Size (USD Millions), (2015-2020)
• Table 19: Idiopathic pulmonary fibrosis (IPF) Spain Market Size (USD Millions), (2011-2014)
• Table 20: Idiopathic pulmonary fibrosis (IPF) Spain Market Size (USD Millions), (2015-2020)
• Table 21: Idiopathic pulmonary fibrosis (IPF) Japan Market Size (USD Millions), (2011-2014)
• Table 22: Idiopathic pulmonary fibrosis (IPF) Japan Market Size (USD Millions), (2015-2020)
• Table 23: Idiopathic pulmonary fibrosis (IPF) ROW Market Size (USD Millions), (2011-2014)
• Table 24: Idiopathic pulmonary fibrosis (IPF) ROW Market Size (USD Millions), (2015-2020)
List of Figures
• Figure 1: Idiopathic pulmonary fibrosis (IPF) Drug Sales (USD Millions), (2011-2014)
• Figure 2: Global Epidemiology of Idiopathic pulmonary fibrosis (IPF) (2011-2020)
• Figure 3: Idiopathic pulmonary fibrosis (IPF) Global Market Size (USD Millions), (2011-2014)
• Figure 4: Idiopathic pulmonary fibrosis (IPF) Global Market Size (USD Millions), (2015-2020)
• Figure 5: Idiopathic pulmonary fibrosis (IPF) US Market Size (USD Millions), (2011-2014)
• Figure 6: Idiopathic pulmonary fibrosis (IPF) US Market Size (USD Millions), (2015-2020)
• Figure 7: Idiopathic pulmonary fibrosis (IPF) Germany Market Size (USD Millions), (2011-2014)
• Figure 8: Idiopathic pulmonary fibrosis (IPF) Germany Market Size (USD Millions), (2015-2020)
• Figure 9: Idiopathic pulmonary fibrosis (IPF) United Kingdom Market Size (USD Millions), (2011-2014)
• Figure 10: Idiopathic pulmonary fibrosis (IPF) United Kingdom Market Size (USD Millions), (2015-2020)
• Figure 11: Idiopathic pulmonary fibrosis (IPF) France Market Size (USD Millions), (2011-2014)
• Figure 12: Idiopathic pulmonary fibrosis (IPF) France Market Size (USD Millions), (2015-2020)
• Figure 13: Idiopathic pulmonary fibrosis (IPF) Italy Market Size (USD Millions), (2011-2014)
• Figure 14: Idiopathic pulmonary fibrosis (IPF) Italy Market Size (USD Millions), (2015-2020)
• Figure 15: Idiopathic pulmonary fibrosis (IPF) Spain Market Size (USD Millions), (2011-2014)
• Figure 16: Idiopathic pulmonary fibrosis (IPF) Spain Market Size (USD Millions), (2015-2020)
• Figure 17: Idiopathic pulmonary fibrosis (IPF) Japan Market Size (USD Millions), (2011-2014)
• Figure 18: Idiopathic pulmonary fibrosis (IPF) Japan Market Size (USD Millions), (2015-2020)
• Figure 19: Idiopathic pulmonary fibrosis (IPF) ROW Market Size (USD Millions), (2011-2014)
• Figure 20: Idiopathic pulmonary fibrosis (IPF) ROW Market Size (USD Millions), (2015-2020)
